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Purpose: To study the association of the single nucleotide polymorphisms (SNPs)  rs17576 and rs2250889 in the
extracellular matrix metalloprotease-9 (MMP-9) gene with primary angle closure glaucoma (PACG) in southern Chinese
patients.
Methods: DNA samples were obtained from 211 adult patients with PACG and 205 control subjects to study the
relationships between SNPs in MMP-9 and PACG. Polymorphism analyses of rs17576 and rs2250889 in MMP-9 were
performed using the polymerase chain reaction,restriction fragment length polymorphism (RFLP), and direct DNA
sequencing techniques. The association between genetic polymorphisms and the risk of PACG were estimated by χ2 test
and logistic regression.
Results: Genotyping of the MMP-9 site (rs2250889) was significantly different between the two groups (P=0.004), and
the odds ratio was OR=1.76 (95%CI: 1.264-2.449). The frequencies of the G/G genotype in the PACG and control groups
were 9% and 2.9%, respectively. However, there were no significant differences between these two groups in the
frequencies of the genotypes and alleles for rs17576 in MMP-9.
Conclusion: The SNP rs2250889 located in MMP-9 might be associated with PACG among southern Chinese people,
and people with the G/G genotype are likely more susceptible to PACG. In contrast, the SNP rs17576 in MMP-9 might
not be related to PACG in the same population.
Glaucoma  is  the  second  leading  cause  of  blindness
worldwide. It is estimated to affect about 70 million people
globally, of which about 6.7 million are bilaterally blind [1].
According to data on the epidemiology of glaucoma, primary
angle closure glaucoma (PACG) is a major form of glaucoma
in  Asia  [2],  especially  in  populations  of  East  Asian  and
Chinese descent [3-5], and the risk of PACG has been reported
to increase with age [6,7].
PACG is characterized by partial or complete anterior
chamber angle closure, which could lead to an increase in
intraocular pressure (IOP), and thus damage to optic nerve. It
has been suggested that a genetic link may be associated with
the  development  of  PACG  in  these  populations  [8].  The
significant differences in incidence and prevalence among
people from different regions are associated primarily with
race, gender [9], and the conditions of anatomical structure
[10,11].  With  aging,  the  anterior  chamber  angles  among
Chinese people become increasingly narrow and the depths of
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their anterior chambers become steadily shallower. PACG
patients are therefore usually found to have certain biometric
ocular features, such as a shallow anterior chamber [12,13],
increased thickness of the lens [14], and short axial length
[15], often accompanied by hypermetropic refraction error
[16].
Extracellular  matrix  remodeling  is  likely  to  be  an
important determinant for the short axial length in relatively
small eyes. Therefore, it is logical that the enhanced activation
of  collagen  degrading  enzymes,  particularly  matrix
metalloproteases (MMPs), might play a role in the remodeling
process  [17].  The  92  kDa  subtype  extracellular  matrix
metalloprotease-9  (MMP-9)  [18],  also  known  as  92  kDa
gelatinase and type V collagenase could degrade type IV
collagen, which is an important component of the extracellular
matrix. It is expressed by the MMP-9 gene with 13 exons,
locating on 20q11.2-q13.1 [19], and it could be produced by
normal mononuclear cells, granulocytes, smooth muscle cells,
vascular endothelial cells, and so on. SNPs in MMP-9 might
cause  a  change  in  function  of  MMP-9  and  thus  affect
extracellular matrix remodeling. A recent study showed that
rs17576  is  associated  with  susceptibility  to  acute  PACG
among Taiwanese patients [20], however, no such association
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1412was found in a similar study focused on Singaporean patients
[21].
This research was a case-control study that considered the
southern Chinese population and aimed to determine whether
the single nucleotide polymorphisms rs17576 and rs2250889
in MMP-9 were related to PACG.
METHODS
Subjects: All of the patients were recruited from the clinics at
Ophthalmic Center at Sun Yat-sen University (Guangzhou,
China). The patients were from the native ethnic Han Chinese
population of southern China. Informed consent conforming
to the tenets of the Declaration of Helsinki was obtained from
each participant prior to the study. Medical and ophthalmic
histories  were  obtained.  Ophthalmological  examinations,
including  visual  acuity,  slit  lamp  biomicroscopy,  anterior
chamber depth, intraocular pressure (IOP) measurement, and
ophthalmoscopic observation were performed by Dr. Liu of
Zhongshan Ophthalmic Center at Sun Yat-sen University. A
total of 211 patients collected in the PACG group met the
following diagnostic criteria: (1) chamber angle closure of at
least  180  degrees;  (2)  IOP  level  over  21  mmHg  using
Goldmann applanation tonometry; (3) typical glaucomatous
visual  defect  by  visual  field  examination;  (4)  typical
glaucomatous optic nerve injury with a C/D ratio over 0.5 by
funduscope examination; and (5) secondary glaucoma was
excluded. In the control group, a total of 205 native southern
Han Chinese individuals with an age range from 55 to 75 years
old were enrolled into the control group according to the
following  criteria:  (1)  no  symptoms  or  signs  of  PACG
mentioned above; (2) glaucoma history and familial glaucoma
history were excluded; and (3) with no ophthalmic diseases
besides cataract.
DNA  extraction,  amplification  and  SNP  site  assessment:
Genomic DNA was prepared from peripheral venous blood
leucocytes. Two pairs of primers (Table 1) designed with
Primer Premier 5 were used to amplify MMP-9 sequences
containing  SNPs  rs17576  and  rs2250889  (NC_000020.9).
The PCR programs used comprised an initial denaturation at
95 °C for 5 min followed by 35 cycles of 95 °C for 30 s, 64
°C/64.2 °C for 30 s, and 72 °C for 30 s. After the last cycle,
the reaction was held at 72 °C for 5 min. The PCR products
were electrophoresed on an agarose gel (1.5%) to confirm the
correct  amplicon  size.  Restriction  enzyme  digestion  was
performed on rs17576 PCR products using the restriction
enzyme  Bsob1  (New  England  Biolabs,  Beijing,  China)
following  the  supplier’s  protocol.  After  digestion,  all
fragments were resolved on polyacrylamide gel (8% PAG,
49:1, 1X TBE) at 15 W for 1 h. Subsequently, the gel was
silver stained the same as for the SSCP analysis described
previously [22]. A single fragment of 211 base pairs (bp) was
identified as homozygous (A/A), three fragments of 222, 172,
and 50 bp were identified as heterozygous (A/G), and two
fragments of 172 and 50 bp were identified as the homozygous
(G/G)  genotype  (Figure  1).  Patient  and  control  samples
containing rs2250889 in MMP-9 were sequenced with the
ABI BigDye Terminator Cycle Sequencing kit v3.1 (ABI
Applied Biosystems, Foster City, CA) [23], using an ABI 377
or  3100  sequencer  (Applied  Biosystems).  The  fragment
containing rs2250889 was amplified and sequenced by the
forward  primer  set.  Comparative  sequencing  analysis
between  these  samples  and  the  standard  sequence
(NC_000020.9) was performed using SeqMan II (DNAStar
Inc., Madison, WI).
Statistical  analysis:  All  detected  SNPs  were  assessed  for
Hardy-Weinberg disequilibrium using the χ2 test. In addition,
the  χ2  test  was  used  to  determine  the  differences  in  the
observed genotype and allele frequencies between the two
groups. These statistical analyses were all performed using
SPSS 13.0. After Bonferroni correction, a p-value < 0.025 was
considered significant (α= 0.05/2 = 0.025).
RESULTS
This research considered 211 PACG patients with a mean age
of  64.8±9.8  (69.2%  females  and  30.8%  males),  and  205
controls with a mean age of 68.0±7.2 (65.8% females and
34.2% males). The data indicated a higher risk of PACG
among  females  in  southern  China,  a  finding  that  was
confirmed in a previous report.
The frequencies of rs17576 and rs2250889 genotypes and
alleles in the PACG and control subjects conformed to the
Hardy-Weinberg  equilibrium.  The  genotype  and  allele
frequencies  of  rs17576  and  rs2250889  in  the  PACG  and
control groups are shown in Table 2. The homozygous A/A
genotype frequency of rs17576 was 7.6% in the PACG group
and 2.9% in control group; however, no significant difference
TABLE 1. PRIMERS FOR EACH PCR PRODUCT CONTAINING RS17576 AND RS2250889.
Name SNP Primer Product length (bp) Primer sequence (5’→3’)
rs17576 A/G Forward CAATTCACCCTCCCGCACTC
Reverse 222 GGAAGATGAATGGAAACTGG
rs2250889 C/G Forward GTATTTGTTCAAGGATGGGTG
Reverse 367 AGACGTTTCGTGGGTTAT
Forward and reverse primers were designed with Primer Primier 5 to amplify the fragments containing rs17576   and rs2250889
in MMP9 . Primer sequences, sizes of PCR products and the annealing temperature used for the amplification are listed above.
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1413was found in the genotype and alleles frequencies between the
PACG and control groups (χ2=4.57, p=0.102). According to
the sequencing result, there were five types of genotype in
fragments containing rs2250889 (Figure 2). The homozygous
G/G, heterozygous G/C and homozygous C/C genotypes of
rs2250889 were 9.0%, 54.0%, and 37.0%, respectively, in the
PACG group and 2.9%, 67.3% and 39.8%, respectively, in the
control  group.  A  significant  difference  in  the  rs2250889
genotype  frequencies  was  found  between  the  PACG  and
control groups (χ2=11.04, p=0.004). A linkage mutation of a
single base (c.1720C>A) in 9 out of 211 subjects in the PACG
group was also detected. The linkage mutation was located
Figure 1. The result of restriction enzyme digestion for rs17567. The
PCR  products  containing  rs17576  were  digested  by  restriction
enzyme Bsob1. Fragment with the G allele in site rs17576 could be
cut into two periods. Lane M stands for the lane of the Marker of 100
bp to 600 bp with intervals of 100 bp ladder; Lane 1 stands for
genotype A/A (222 bp); Lane 2 stands for genotype A/G (222 bp,
172 bp, and 50bp); Lane 3 stands for genotype G/G (172 bp and 50
bp).
just before the site of SNP rs2250889 (c.1721C>G). When the
allele at the site of rs2250889 was G, the base just before it
might change from C to A. None of these mutations were
observed  among  the  subjects  in  the  control  group.  This
mutation did not change the amino acid encoding, and it was
a new SNP that had not been reported previously.
DISCUSSION
Primary angle-closure glaucoma (PACG) is a major cause of
visual morbidity in East Asia and China, and it is expected to
become an even more serious problem as world population
and longevity increases. Racial differences in the prevalence
of  PACG  and  the  familial  tendency  towards  the  disease
suggest a genetic basis for the condition. Our study is the first
Figure 2. Five genotypes of Direct sequencing map for rs2250889 in
MMP9 are shown. The single base directed with a black arrowhead
was the SNP site rs2250889. The two bases collected in the black
frame were two single nucleotide polymorphisms. The single base
before site rs2250889 was a new SNP found in our research, and it
was a linkage mutation, which did not change amino acid coding.
Genotypes of rs2250889 in A, B, C, D, and E were separately C/G,
G/G, C/G, C/C, G/G, while genotypes of the single base before it in
A, B, C, D, and E were separately A/C, A/C, C/C, C/C, C/C.
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2to report an association of the SNP rs2250889 in MMP-9 with
PACG.  Further,  it  is  the  first  in  China  to  discuss  the
association of rs17576 in MMP-9 with PACG among the
native southern Chinese population. Through a case-control
study, we found a significant association between rs2250889
in MMP-9 and PACG (p=0.004). This finding suggests that
rs2250889 in MMP-9 might be a risk factor for PACG in the
southern Chinese population.
MMP-9 is located in chromosome 20q11.2-q13.1 and
contains  13  exons.  Some  research  has  shown  that  using
ELISA, in both pro and active forms of MMP-9 (GLB) bind
to type-I and type-IV collagens, gelatin and laminin [24].
Matrix  metalloprotease-9  cleaves  type  IV  collagen  and  is
important for the remodeling of the ECM. Liu et al [25]. found
a decreased mRNA transcription of MMP-9 in the Tenon’s
capsule  in  PACG.  Altered  enzyme  activities  might  be
attributable to variants in or near this gene. For example,
variants  located  in  the  promoter  region  of  a  gene
predominantly affect the transcriptional activity and therefore
the  gene  expression,  while  an  amino  acid  change  of
nonsynonymous SNPs in the coding region could also affect
the protein’s tertiary structure and thus its biophysical and
biochemical  activity.  SNPs  rs17576  and  rs2250889  are
nonsynonymous single base changes in coding regions, and
their change might play a role in the structure and function of
protein  MMP-9.  Located  in  the  second  COOH-terminal
hemopexin-like domain of MMP-9,rs2250889 (c.1721C>G,
p.574P>R)  represents  a  substantial  change  since  Pro  is  a
cyclic, nonpolar amino acid while Arg is basic and has a
positive charge [26]. SNP in MMP-9 rs17576 (c.836G>A, p.
279Q>R) is a nonconservative amino acid substitution that
resides  within  the  highly  conserved  gelatinase-specific
fibronectin type II domain (FN2) [24], which presumably
enhances  substrate  binding.  These  residues  might  have
significant  interactions  with  surrounding  residues,  so
variations in these amino acids could affect protein stability
and function.
Recently,  the  association  of  SNPs  in  potential  genes
(MMP-9) with PACG has been studied by several researchers
in Taiwan and other nations. Taiwanese researchers suggested
an association of SNP rs17576 with acute PACG in a case-
control  study  comprised  of  78  patients  and  86  controls.
Singaporean researchers found no association of rs17576 with
PACG among 217 PACG patients (85 acute PACG and 132
chronic PACG) and 83 controls. The results of the association
study between SNPs in genes with diseases would be affected
greatly by the number of subjects and ethnic distribution. In
our study, all subjects were from the native southern Han
Chinese population. Further, the number of subjects in the
PACG and control groups were above 200, and subjects in the
two groups were age and gender-matched. The data indicated
a significant association of rs2250889 with susceptibility to
PACG, but the exact mechanism by which it affected the
function  of  MMP-9  was  not  known.  The  patients  in  our
research  have  regular  axial  length  and  no  obvious
microphthalmia.  Although  our  results  suggested  an
association  of  this  SNP  with  PACG,  we  were  uncertain
whether this SNP was related determinately to PACG. Our
results did not support a significant association of rs17576
with PACG, but the frequency of the A/A genotype was much
higher in the PACG group than in the control group.
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